Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Philips Signs Deal With Medipol University Hospital In Turkey - Quick Facts

RELATED NEWS
Trade PHG now with 

Royal Philips Electronics (PHG: Quote,PHGFF.PK) said it signed a major deal with Medipol University Hospital in Turkey, which will see advanced Philips solutions installed in its new 500-bed hospital in Istanbul, Bagcilar. The deal is worth approximately 13 million euros.

The deal will see Philips install a wide range of its newest cardiology and oncology technologies in the hospital, including some devices for which this will mark their first install anywhere in Turkey. In addition, Philips will be installing general lighting throughout the hospital, as well as consulting on workflow design, to ensure an optimum experience for both patients and staff alike.

Two imaging systems included in the deal and which will be unique to the Medipol Hospital in Turkey, are the Philips BrightView XCT and the Philips Sonalleve MR HIFU system.

In addition, the Medipol Hospital will also be equipped with a sleep lab facility which will benefit from the latest Philips technologies, including the Alice 6 LDx and LDE polysomnography sleep diagnostic systems.

Click here to receive FREE breaking news email alerts for Koninklijke Philips Electronics NV and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Toyota Motor Corp. (TM, TYT.L) Thursday announced 1.1 percent decline in worldwide production for October, as there was a sharp decline in production of passenger cars in Japan. Production outside Japan improved 2.3 percent. In a separate announcement, the Japanese automaker said it will recall more... Computer and printer maker Hewlett-Packard Co. said Tuesday after the markets closed that its fourth quarter profit fell 6% from last year, as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.